You are here

Home

COURAGE THERAPEUTICS INC

Company Information
Address
64 HOMER ST
NEWTON CENTER, MA 02459-1517
United States


http://www.couragetx.com
Information

UEI: W841GEJ8ADX7

# of Employees: 2
Ownership Information

HUBZone Owned: No

Socially and Economically Disadvantaged: No

Woman Owned: No

Award Charts




Award Listing

  • Record 1 TO 3

  1. Development of Novel Melanocortin-4 Receptor Peptide Agonists for the Treatment ofMC4R Haploinsufficiency

    Amount: $806,879.00

    The melanocortin peptide therapeutic setmelanotide, (ImcivreeTM), is highly effective in the treatment of the rare obesity syndromes, POMC and leptin receptor deficiency. However, the drug is ineffect ...

    STTRPhase II2022Department of Health and Human Services National Institutes of Health

  2. Development of Melanocortin-3 Receptor Peptide Agonists for the Treatment of Anorexia Nervosa

    Amount: $250,538.00

    Anorexia nervosa (AN) is a devastating neuropsychiatric disease with a high prevalence (up to 2.2% of women) and significant morbidity and mortality. There are currently no effective therapeutic agent ...

    STTRPhase I2021Department of Health and Human Services National Institutes of Health

  3. Development of Melanocortin-3 Receptor Peptide Antagonists for the Treatment of Obesity and Maintenance of Weight Loss

    Amount: $244,905.00

    Rates of obesity have steadily increased in the United States, with approximately 50 percent of Americans projected to be classified as obese by 2030. Interestingly, obesity even seems to be a risk fa ...

    STTRPhase I2020Department of Health and Human Services National Institutes of Health
US Flag An Official Website of the United States Government